HCM · HUTCHMED (China) Limited ADR
United States · RS rating 51 · As of 2026-10-14
| Price | 13.48 USD |
|---|---|
| 1-day change | -0.1% |
| RS rating (overall / 1M / 3M / 12M) | 51 / 51 / 89 / 31 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 27 / 33 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +16.0% |
| Market cap (USD) | $2.4B |